Group 2A: HER2+ Breast Cancer; Biomarkers; Real-World Data/Outcomes; Tumor Biology

Poster # 1101: Actionability of comprehensive genomic profiling compared to the tissue-based and plasma-based assay in patients with metastatic breast cancer: A real-world study

Poster #1016: The association of centromere amplification and response to trastuzumab in HER2+ metastatic breast cancer